Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
Jakko van Ingen, Timothy Aksamit, Claire Andrejak, Erik C. Böttger, Emmanuelle Cambau, Charles L. Daley, David E. Griffith, Lorenzo Guglielmetti, Steven M. Holland, Gwen A. Huitt, Won-Jung Koh, Christoph Lange, Philip Leitman, Theodore K. Marras, Kozo Morimoto, Kenneth N. Olivier, Miguel Santin, Jason E. Stout, Rachel Thomson, Enrico Tortoli, Richard J. Wallace, Kevin L. Winthrop, Dirk Wagner
Source: Eur Respir J, 51 (3) 1800170; 10.1183/13993003.00170-2018
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jakko van Ingen, Timothy Aksamit, Claire Andrejak, Erik C. Böttger, Emmanuelle Cambau, Charles L. Daley, David E. Griffith, Lorenzo Guglielmetti, Steven M. Holland, Gwen A. Huitt, Won-Jung Koh, Christoph Lange, Philip Leitman, Theodore K. Marras, Kozo Morimoto, Kenneth N. Olivier, Miguel Santin, Jason E. Stout, Rachel Thomson, Enrico Tortoli, Richard J. Wallace, Kevin L. Winthrop, Dirk Wagner. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J, 51 (3) 1800170; 10.1183/13993003.00170-2018
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Guideline 2020 Year: 2020
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020 Year: 2020
Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease Source: Eur Respir J, 53 (5) 1801636; 10.1183/13993003.01636-2018 Year: 2019
Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease Source: Eur Respir Monogr 2018; 81: 204-221 Year: 2018
New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Source: Virtual Congress 2020 – German programme 2020 Year: 2020
Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease Source: Eur Respir J, 55 (1) 1901300; 10.1183/13993003.01300-2019 Year: 2020
The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases Source: Eur Respir J , 49 (2) 1601855; DOI: 10.1183/13993003.01855-2016 Year: 2017
Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019
Clinical analysisof patients with pulmonary nontuberculous mycobacterial disease complicated with pneumothorax Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research Source: Eur Respir J, 49 (6) 1700051; 10.1183/13993003.00051-2017 Year: 2017
New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Year: 2020
Treatment of pulmonary NTM infection: can it be done? Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge Year: 2007
Patient reported outcomes for non-tuberculous mycobacterial disease Source: Eur Respir J, 55 (1) 1902204; 10.1183/13993003.02204-2019 Year: 2020
Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018
Link between clinical severity of osteoarticular tuberculosis and the combined presence of pulmonary tuberculosis Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009